Department of Neurology, General Hospital of Northern Theater Command
Shenyang, 110016, China
NCT Number: NCT05451030
Cerebral circulation time in patients with severe carotid artery stenosis was found to be associated with hyperperfusion syndrome. Remote ischemic preconditioning can change the ability of cerebral autoregulation. The prospective, randomized controlled, blind outcome evaluation, multi-center study aimed to investigate the effect of remote ischemic preconditioning on cerebral circulation time in patients with severe carotid artery stenosis.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Shenyang, 110016, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The cuff of a pneumatic electronic auto-control device placed around the bilateral upper limbs was used to deliver the protocol: 5 cycles of cuff inflation (200mmHg for 5 minutes) and deflation (for 5 minutes), for a total procedure time of 50 minutes, twice daily from the first DSA to the day of carotid artery stenting.
Time frame: pre-intervention
Time frame: 1 hours and 24 hours after carotid artery stenting
Time frame: pre-intervention
Time frame: 24 hours and 7 days after carotid artery stenting
General Hospital of Shenyang Military Region
Other
The Effect of Remote Ischemic Preconditioning on Cerebral Circulation Time in Patients With Severe Carotid Artery Stenosis (RIP-CCT): A Prospective, Randomized Controlled, Blind Outcome Evaluation, Multi-center Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06935279
Arterial Occlusive Diseases, Arteriosclerosis
Xian, Shanxi, China
View Trial DetailsNCT07204678
Arterial Occlusive Diseases, Brain Diseases
Tulln, Austria
View Trial DetailsNCT06033963
Arterial Occlusive Diseases, Brain Diseases
Changchun, Jilin, China
View Trial DetailsNCT05117515
Arterial Occlusive Diseases, Brain Diseases
Düsseldorf, North Rhine-Westphalia, Germany
View Trial Details